ALEC compared with SLN: revenue, margins and what each company keeps, and the suppliers and customers both name

ALECAlector, Inc.

Mkt capRevenueRevenue

SLNSilence Therapeutics plc

Mkt capRevenueRevenue

Compare

ALECAlector, Inc.

SLNSilence Therapeutics plc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ALEC

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±39.7%▼−2.73%×0.07

May 8 '26±13.1%▼−13.93%×1.06

Q1 FY26±31.5%▲+7.11%×0.23

Nov 7 '25±80.9%▼−1.54%×0.02

SLN

No earnings history for SLN.

= impliedALEC realized, solidSLN realized, hatchedOne scale, both sides: full bar = 81%× = |realized| ÷ impliedSource: market data

ALECAlector, Inc.

2.20▼−1.79%· post 2.20

Mkt cap$246.8MRevenue$3MQ2 FY26Revenue$21MFY25

SLNSilence Therapeutics plc

19.76▼−0.20%· post 19.76

ClosedOct 30 '26

Mkt cap$933.1MRevenue$422,000Q1 FY26Revenue$559,000FY25

Compare

ClosedOct 30 '26

ALECAlector, Inc.

SLNSilence Therapeutics plc

2.20▼−1.79%post 2.20

Price

19.76▼−0.20%post 19.76

$246.8M

Mkt cap

$933.1M

Q2 FY26$3M

Revenue

$422,000Q1 FY26

FY25$21M

Revenue

$559,000FY25

ALEC2.20▼−1.79%vsSLN19.76▼−0.20%ClosedOct 30 '26